Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata4
|
ENSMUSG00000021944.9 | GATA binding protein 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_63268302_63270010 | Gata4 | 1968 | 0.309115 | 0.85 | 9.4e-18 | Click! |
chr14_63240390_63241194 | Gata4 | 4456 | 0.200169 | 0.84 | 3.6e-17 | Click! |
chr14_63243823_63244000 | Gata4 | 1337 | 0.418540 | 0.84 | 4.5e-17 | Click! |
chr14_63270328_63271232 | Gata4 | 344 | 0.871923 | 0.84 | 5.8e-17 | Click! |
chr14_63241333_63241857 | Gata4 | 3653 | 0.215050 | 0.84 | 7.0e-17 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_31612888_31614126 | 10.80 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr9_105520039_105521535 | 9.82 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr10_93672331_93673286 | 8.73 |
Gm8580 |
predicted gene 8580 |
6962 |
0.14 |
chr1_118481967_118482873 | 7.89 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr7_99824758_99826479 | 7.84 |
Neu3 |
neuraminidase 3 |
2799 |
0.17 |
chr6_97929540_97930859 | 7.81 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr7_110773542_110774597 | 7.53 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr13_38579867_38580777 | 7.48 |
Gm40922 |
predicted gene, 40922 |
25457 |
0.11 |
chr8_80497324_80498362 | 7.45 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr7_113295089_113296008 | 7.32 |
Gm45355 |
predicted gene 45355 |
211 |
0.93 |
chr8_122282630_122283784 | 7.26 |
Zfpm1 |
zinc finger protein, multitype 1 |
1066 |
0.46 |
chr2_17460205_17460550 | 7.20 |
Nebl |
nebulette |
244 |
0.96 |
chr7_81057643_81058977 | 7.00 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr15_83169748_83171160 | 6.98 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr6_122393478_122393837 | 6.89 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
2278 |
0.21 |
chr2_84936571_84938205 | 6.66 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr17_45592643_45594205 | 6.59 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
210 |
0.86 |
chr7_19290671_19291896 | 6.56 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr19_34253411_34255499 | 6.51 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr9_50752994_50754649 | 6.46 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr5_147623817_147624228 | 6.46 |
Flt1 |
FMS-like tyrosine kinase 1 |
8780 |
0.23 |
chr10_93454496_93455097 | 6.33 |
Lta4h |
leukotriene A4 hydrolase |
1345 |
0.38 |
chr8_34096835_34098006 | 6.32 |
Dctn6 |
dynactin 6 |
271 |
0.85 |
chr10_45048086_45048775 | 6.21 |
Prep |
prolyl endopeptidase |
18773 |
0.15 |
chr6_56920828_56921008 | 6.20 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
2806 |
0.17 |
chr8_84701273_84703379 | 6.15 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr12_111028723_111029009 | 6.12 |
Gm48631 |
predicted gene, 48631 |
10464 |
0.12 |
chr1_125678382_125678847 | 6.11 |
Gpr39 |
G protein-coupled receptor 39 |
1619 |
0.44 |
chr7_120879515_120880256 | 6.10 |
Eef2k |
eukaryotic elongation factor-2 kinase |
3665 |
0.15 |
chr14_63231019_63231782 | 5.94 |
Gata4 |
GATA binding protein 4 |
13848 |
0.16 |
chr6_136857054_136858156 | 5.93 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr16_44765772_44766414 | 5.91 |
Cd200r1 |
CD200 receptor 1 |
267 |
0.88 |
chr5_105409514_105410008 | 5.89 |
Gm32051 |
predicted gene, 32051 |
394 |
0.82 |
chr5_117133717_117134877 | 5.86 |
Taok3 |
TAO kinase 3 |
656 |
0.62 |
chr15_44457385_44458529 | 5.85 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
404 |
0.83 |
chr9_21029266_21030734 | 5.80 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr14_79535326_79536502 | 5.79 |
Elf1 |
E74-like factor 1 |
20216 |
0.14 |
chr5_100570574_100571670 | 5.69 |
Plac8 |
placenta-specific 8 |
1070 |
0.43 |
chr2_26012995_26013283 | 5.69 |
Ubac1 |
ubiquitin associated domain containing 1 |
2186 |
0.22 |
chr10_40140777_40141166 | 5.68 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1283 |
0.36 |
chr11_102363631_102364272 | 5.68 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr6_41701642_41702158 | 5.64 |
Kel |
Kell blood group |
2439 |
0.19 |
chr11_100931288_100932301 | 5.60 |
Stat3 |
signal transducer and activator of transcription 3 |
7586 |
0.15 |
chr4_134864478_134865098 | 5.54 |
Rhd |
Rh blood group, D antigen |
252 |
0.91 |
chr17_69105006_69106089 | 5.53 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
21453 |
0.26 |
chr11_22170917_22171472 | 5.50 |
Ehbp1 |
EH domain binding protein 1 |
216 |
0.96 |
chr6_137931136_137931732 | 5.49 |
Gm24308 |
predicted gene, 24308 |
11463 |
0.27 |
chr1_36272569_36273936 | 5.48 |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
183 |
0.93 |
chr18_50028322_50029158 | 5.47 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2278 |
0.32 |
chr9_24769617_24771807 | 5.40 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr2_160326169_160327486 | 5.39 |
Gm826 |
predicted gene 826 |
667 |
0.78 |
chr6_14754647_14755330 | 5.35 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
286 |
0.95 |
chr16_38363598_38364152 | 5.33 |
Popdc2 |
popeye domain containing 2 |
1630 |
0.26 |
chr8_111573318_111574249 | 5.33 |
Znrf1 |
zinc and ring finger 1 |
11943 |
0.18 |
chr18_11051784_11053949 | 5.28 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr10_93143259_93144113 | 5.27 |
Cdk17 |
cyclin-dependent kinase 17 |
17189 |
0.17 |
chr2_90869871_90870903 | 5.26 |
Mtch2 |
mitochondrial carrier 2 |
6928 |
0.11 |
chr2_91949326_91950727 | 5.19 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr5_64810297_64813272 | 5.18 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr16_85132591_85133705 | 5.13 |
Gm49226 |
predicted gene, 49226 |
15681 |
0.18 |
chr4_154926952_154928851 | 5.12 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr8_61900734_61900909 | 5.10 |
Palld |
palladin, cytoskeletal associated protein |
1848 |
0.32 |
chr2_103483073_103483738 | 5.07 |
Cat |
catalase |
1720 |
0.36 |
chr9_48362102_48362695 | 5.06 |
Nxpe4 |
neurexophilin and PC-esterase domain family, member 4 |
357 |
0.87 |
chr3_97076352_97076977 | 5.05 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16121 |
0.15 |
chr17_35200817_35202291 | 5.04 |
Tnf |
tumor necrosis factor |
450 |
0.46 |
chr14_105565805_105566636 | 5.04 |
9330188P03Rik |
RIKEN cDNA 9330188P03 gene |
23256 |
0.16 |
chr7_44479611_44481283 | 5.03 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4070 |
0.08 |
chr2_103958009_103958847 | 5.00 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr3_144198213_144200687 | 4.98 |
Gm43445 |
predicted gene 43445 |
188 |
0.94 |
chr1_161766766_161767491 | 4.97 |
Gm5049 |
predicted gene 5049 |
21072 |
0.12 |
chr2_163356404_163356958 | 4.95 |
Tox2 |
TOX high mobility group box family member 2 |
36303 |
0.11 |
chr8_80868770_80869328 | 4.95 |
Gm31105 |
predicted gene, 31105 |
10891 |
0.18 |
chr6_139586816_139587911 | 4.93 |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma |
126 |
0.96 |
chr17_26849670_26851386 | 4.92 |
Nkx2-5 |
NK2 homeobox 5 |
5519 |
0.11 |
chr10_69785224_69786670 | 4.90 |
Ank3 |
ankyrin 3, epithelial |
422 |
0.91 |
chr7_24372002_24372258 | 4.90 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1792 |
0.18 |
chr12_108503155_108504028 | 4.90 |
Eml1 |
echinoderm microtubule associated protein like 1 |
31220 |
0.14 |
chr11_117781898_117782456 | 4.89 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr10_98624508_98624896 | 4.89 |
Gm5427 |
predicted gene 5427 |
75008 |
0.11 |
chr11_61075424_61076210 | 4.89 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
10013 |
0.17 |
chr7_100465236_100467118 | 4.87 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr2_146099003_146099353 | 4.83 |
Cfap61 |
cilia and flagella associated protein 61 |
51927 |
0.15 |
chr13_43235236_43235916 | 4.83 |
Tbc1d7 |
TBC1 domain family, member 7 |
64075 |
0.1 |
chr9_64806162_64806616 | 4.82 |
Dennd4a |
DENN/MADD domain containing 4A |
4951 |
0.23 |
chr18_11047852_11049020 | 4.79 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr12_13180713_13181236 | 4.79 |
Gm24208 |
predicted gene, 24208 |
17211 |
0.16 |
chr18_62174392_62175675 | 4.75 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr10_8130265_8131012 | 4.73 |
Gm30906 |
predicted gene, 30906 |
45493 |
0.17 |
chr10_79417219_79417524 | 4.73 |
Gm47015 |
predicted gene, 47015 |
534 |
0.77 |
chr1_174173964_174174767 | 4.73 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1589 |
0.22 |
chr7_24371543_24371978 | 4.73 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1422 |
0.22 |
chr10_115817324_115818606 | 4.71 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr8_33926179_33926910 | 4.70 |
Rbpms |
RNA binding protein gene with multiple splicing |
2732 |
0.25 |
chr18_68230321_68230918 | 4.69 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2552 |
0.27 |
chrX_150550830_150551424 | 4.68 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2910 |
0.2 |
chr7_36166793_36167655 | 4.67 |
Rpl17-ps9 |
ribosomal protein L17, pseudogene 9 |
48950 |
0.14 |
chr2_156776920_156777878 | 4.67 |
Myl9 |
myosin, light polypeptide 9, regulatory |
1118 |
0.36 |
chr2_17459795_17460084 | 4.66 |
Nebl |
nebulette |
682 |
0.8 |
chr8_39010738_39011315 | 4.66 |
Tusc3 |
tumor suppressor candidate 3 |
5116 |
0.27 |
chr10_98624940_98625347 | 4.65 |
Gm5427 |
predicted gene 5427 |
74567 |
0.11 |
chr19_5724002_5724609 | 4.62 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
1965 |
0.11 |
chr15_12193885_12195324 | 4.60 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr17_62748947_62749663 | 4.57 |
Efna5 |
ephrin A5 |
131839 |
0.06 |
chr19_56389633_56389987 | 4.55 |
Nrap |
nebulin-related anchoring protein |
67 |
0.97 |
chr8_122546551_122549259 | 4.55 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr15_41751298_41752572 | 4.54 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr14_75139045_75139365 | 4.53 |
Gm15628 |
predicted gene 15628 |
2293 |
0.23 |
chr12_36436829_36437360 | 4.52 |
D630036H23Rik |
RIKEN cDNA D630036H23 gene |
54913 |
0.11 |
chr6_90623236_90623734 | 4.52 |
Slc41a3 |
solute carrier family 41, member 3 |
4338 |
0.16 |
chr3_137968340_137969523 | 4.52 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12599 |
0.12 |
chr9_48338929_48340200 | 4.51 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr11_78072614_78073453 | 4.50 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr19_25343674_25344266 | 4.50 |
Gm34432 |
predicted gene, 34432 |
3233 |
0.31 |
chr9_32699930_32700500 | 4.49 |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
3831 |
0.22 |
chr15_80250501_80251371 | 4.46 |
Mief1 |
mitochondrial elongation factor 1 |
3305 |
0.13 |
chr17_40811481_40812037 | 4.44 |
Rhag |
Rhesus blood group-associated A glycoprotein |
575 |
0.7 |
chr8_13202537_13203450 | 4.44 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2173 |
0.16 |
chr5_116021804_116022431 | 4.43 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
471 |
0.73 |
chr8_80496570_80496939 | 4.43 |
Gypa |
glycophorin A |
2973 |
0.3 |
chr11_117798237_117798922 | 4.43 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
919 |
0.33 |
chr16_18429039_18430122 | 4.42 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chrX_150547515_150548479 | 4.40 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr14_63367655_63368646 | 4.40 |
Blk |
B lymphoid kinase |
8268 |
0.16 |
chr15_97379421_97380753 | 4.39 |
Pced1b |
PC-esterase domain containing 1B |
18870 |
0.24 |
chr10_111582974_111583647 | 4.39 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
10963 |
0.16 |
chr10_95970803_95971600 | 4.39 |
Eea1 |
early endosome antigen 1 |
30444 |
0.15 |
chr6_99172721_99173535 | 4.37 |
Foxp1 |
forkhead box P1 |
10110 |
0.29 |
chr3_100486792_100487398 | 4.36 |
Tent5c |
terminal nucleotidyltransferase 5C |
2099 |
0.23 |
chr15_94249513_94250124 | 4.35 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
154440 |
0.04 |
chr4_40849281_40849945 | 4.35 |
Mir5123 |
microRNA 5123 |
525 |
0.38 |
chr9_101198368_101199080 | 4.35 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr10_111594457_111595800 | 4.33 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
855 |
0.55 |
chr14_70621516_70621961 | 4.33 |
Dmtn |
dematin actin binding protein |
3193 |
0.15 |
chr10_69981635_69981988 | 4.33 |
Ank3 |
ankyrin 3, epithelial |
313 |
0.94 |
chr8_122284632_122284861 | 4.33 |
Zfpm1 |
zinc finger protein, multitype 1 |
2605 |
0.23 |
chr1_120267677_120268469 | 4.32 |
Steap3 |
STEAP family member 3 |
2350 |
0.36 |
chr12_88984474_88985246 | 4.32 |
Nrxn3 |
neurexin III |
31461 |
0.23 |
chr12_117657998_117660727 | 4.32 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr19_17354797_17355050 | 4.32 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1744 |
0.41 |
chr13_30345209_30345549 | 4.29 |
Agtr1a |
angiotensin II receptor, type 1a |
162 |
0.96 |
chr13_41018072_41019454 | 4.27 |
Tmem14c |
transmembrane protein 14C |
2471 |
0.18 |
chr16_44015370_44016774 | 4.27 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr11_109587022_109588156 | 4.27 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr18_76200378_76201192 | 4.27 |
Gm9028 |
predicted gene 9028 |
23398 |
0.15 |
chr15_44484811_44485159 | 4.25 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
27432 |
0.16 |
chr3_122247075_122247647 | 4.25 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1280 |
0.26 |
chr2_146098449_146098737 | 4.25 |
Cfap61 |
cilia and flagella associated protein 61 |
51342 |
0.15 |
chr3_144759885_144761021 | 4.23 |
Clca3a1 |
chloride channel accessory 3A1 |
388 |
0.78 |
chr6_101271529_101272523 | 4.23 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
16484 |
0.18 |
chr15_62098940_62099612 | 4.22 |
Pvt1 |
Pvt1 oncogene |
247 |
0.95 |
chr18_12258021_12258704 | 4.22 |
Ankrd29 |
ankyrin repeat domain 29 |
13335 |
0.15 |
chr11_11836398_11837549 | 4.22 |
Ddc |
dopa decarboxylase |
693 |
0.68 |
chr7_3666562_3667626 | 4.22 |
Tmc4 |
transmembrane channel-like gene family 4 |
211 |
0.74 |
chr6_143832506_143833713 | 4.22 |
Sox5 |
SRY (sex determining region Y)-box 5 |
113979 |
0.06 |
chr3_116389021_116389748 | 4.22 |
Cdc14a |
CDC14 cell division cycle 14A |
16104 |
0.15 |
chr1_185515159_185516225 | 4.21 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18304 |
0.17 |
chr1_133799053_133799204 | 4.19 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
1908 |
0.26 |
chr5_43841417_43842133 | 4.19 |
Bst1 |
bone marrow stromal cell antigen 1 |
4661 |
0.12 |
chr10_63457257_63458786 | 4.19 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr1_43196103_43196958 | 4.18 |
Fhl2 |
four and a half LIM domains 2 |
231 |
0.93 |
chr2_51072525_51072965 | 4.18 |
Rnd3 |
Rho family GTPase 3 |
76349 |
0.11 |
chr14_34587287_34588669 | 4.17 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chr6_97311036_97312726 | 4.16 |
Frmd4b |
FERM domain containing 4B |
499 |
0.83 |
chr10_68231270_68231995 | 4.16 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
47089 |
0.15 |
chr2_129201084_129201673 | 4.15 |
Slc20a1 |
solute carrier family 20, member 1 |
2068 |
0.15 |
chr17_84776246_84777200 | 4.15 |
Lrpprc |
leucine-rich PPR-motif containing |
820 |
0.59 |
chr8_122719956_122721464 | 4.15 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
17801 |
0.09 |
chr12_31863177_31863445 | 4.13 |
Gm25913 |
predicted gene, 25913 |
4853 |
0.19 |
chr3_19648029_19648209 | 4.12 |
Trim55 |
tripartite motif-containing 55 |
3611 |
0.19 |
chr3_128990459_128991248 | 4.12 |
Gm9387 |
predicted pseudogene 9387 |
35755 |
0.19 |
chr19_55126480_55127385 | 4.10 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
271 |
0.92 |
chr15_34899912_34900379 | 4.08 |
Stk3 |
serine/threonine kinase 3 |
60092 |
0.12 |
chr3_41522196_41522994 | 4.08 |
2400006E01Rik |
RIKEN cDNA 2400006E01 gene |
622 |
0.65 |
chr17_48431455_48432112 | 4.05 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr2_91119045_91119896 | 4.04 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr15_25941347_25942080 | 4.04 |
Retreg1 |
reticulophagy regulator 1 |
826 |
0.63 |
chr18_62178475_62179981 | 4.03 |
Adrb2 |
adrenergic receptor, beta 2 |
731 |
0.49 |
chr4_151012060_151012982 | 4.03 |
Per3 |
period circadian clock 3 |
3624 |
0.19 |
chr11_65795055_65795210 | 4.02 |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
6835 |
0.21 |
chr1_173333573_173334024 | 4.02 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
48 |
0.97 |
chr6_24602042_24602241 | 4.02 |
Lmod2 |
leiomodin 2 (cardiac) |
4379 |
0.17 |
chr14_63246144_63246295 | 4.02 |
Gata4 |
GATA binding protein 4 |
948 |
0.55 |
chr16_89830219_89830776 | 4.01 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
7378 |
0.3 |
chr13_93239462_93239901 | 4.00 |
Tent2 |
terminal nucleotidyltransferase 2 |
47296 |
0.11 |
chr10_40737288_40738233 | 4.00 |
Mettl24 |
methyltransferase like 24 |
54478 |
0.13 |
chr16_16214897_16215480 | 4.00 |
Pkp2 |
plakophilin 2 |
1870 |
0.35 |
chr17_26844031_26845183 | 4.00 |
Nkx2-5 |
NK2 homeobox 5 |
402 |
0.75 |
chr8_85380167_85381092 | 4.00 |
Mylk3 |
myosin light chain kinase 3 |
349 |
0.83 |
chr10_108595779_108596540 | 3.99 |
Syt1 |
synaptotagmin I |
40805 |
0.18 |
chr2_114049476_114049927 | 3.99 |
Actc1 |
actin, alpha, cardiac muscle 1 |
3186 |
0.2 |
chr17_62655730_62656448 | 3.99 |
Gm25800 |
predicted gene, 25800 |
198969 |
0.03 |
chr3_101551232_101552184 | 3.96 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25852 |
0.16 |
chr10_62332356_62333129 | 3.95 |
Hk1 |
hexokinase 1 |
4975 |
0.18 |
chr9_70682353_70682679 | 3.94 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
3500 |
0.22 |
chr7_80542241_80542698 | 3.94 |
Blm |
Bloom syndrome, RecQ like helicase |
7350 |
0.17 |
chr12_83072442_83073418 | 3.94 |
Rgs6 |
regulator of G-protein signaling 6 |
25940 |
0.15 |
chr14_70623688_70624289 | 3.93 |
Dmtn |
dematin actin binding protein |
2167 |
0.19 |
chr17_25089311_25089630 | 3.92 |
Ift140 |
intraflagellar transport 140 |
1201 |
0.31 |
chr4_117312229_117313344 | 3.91 |
Rnf220 |
ring finger protein 220 |
12758 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
4.2 | 12.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.1 | 12.4 | GO:0003175 | tricuspid valve development(GO:0003175) |
3.1 | 9.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.0 | 6.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.9 | 8.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.7 | 13.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.6 | 7.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.3 | 7.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.3 | 7.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.2 | 4.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.2 | 6.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
2.2 | 6.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.1 | 6.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.0 | 6.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.0 | 2.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.0 | 2.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.9 | 15.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.9 | 7.5 | GO:0032264 | IMP salvage(GO:0032264) |
1.9 | 5.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 5.2 | GO:1903416 | response to glycoside(GO:1903416) |
1.7 | 5.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.6 | 4.8 | GO:0002432 | granuloma formation(GO:0002432) |
1.5 | 9.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.5 | 4.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.5 | 5.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.5 | 8.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.5 | 4.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.5 | 4.4 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 4.3 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 7.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.4 | 4.3 | GO:0042117 | monocyte activation(GO:0042117) |
1.4 | 14.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.3 | 4.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.3 | 1.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.3 | 1.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.2 | 5.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 1.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.2 | 1.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
1.2 | 3.7 | GO:0061010 | gall bladder development(GO:0061010) |
1.2 | 2.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.1 | 6.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.1 | 6.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.1 | 4.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 3.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 26.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.1 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.1 | 2.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.1 | 6.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.1 | 3.2 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.0 | 3.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.0 | 9.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 3.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 3.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.0 | 8.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.0 | 4.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.0 | 3.0 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
1.0 | 3.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.0 | 3.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.0 | 5.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.0 | 3.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.0 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 2.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 2.8 | GO:0035483 | gastric emptying(GO:0035483) |
0.9 | 0.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.9 | 4.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 3.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 1.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.9 | 2.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.8 | 2.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 3.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 2.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 0.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 2.4 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.8 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 3.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 2.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.8 | 2.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 0.8 | GO:0048382 | mesendoderm development(GO:0048382) |
0.8 | 2.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.8 | 2.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.8 | 3.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 5.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.7 | 3.0 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.7 | 3.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 2.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 5.9 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.7 | 4.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 5.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 2.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.7 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.7 | 0.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.7 | 2.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 4.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 6.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 2.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.7 | 3.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.7 | 2.8 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.7 | 2.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.7 | 4.9 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 1.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 2.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 2.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 2.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 3.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 4.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.7 | 0.7 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 4.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 5.3 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 2.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 4.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.7 | 2.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 1.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.6 | 1.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 3.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 11.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 1.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 0.6 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.6 | 1.9 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.2 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.6 | 2.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 1.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 4.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 2.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.6 | 0.6 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.6 | 3.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 1.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 3.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 5.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 2.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 1.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 6.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 8.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 3.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 2.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.6 | 4.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 1.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 1.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 5.9 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.6 | 2.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.6 | 4.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 1.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.6 | 1.7 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.6 | 8.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 0.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 1.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.6 | 1.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.6 | 5.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.6 | 1.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.6 | 1.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 1.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.6 | 1.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 2.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.5 | 3.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 1.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 1.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 2.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.5 | 3.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.5 | 2.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 3.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.5 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 1.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 11.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.5 | 1.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.5 | 1.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.5 | 3.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.5 | 1.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 2.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 4.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 1.5 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.5 | 2.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.5 | 2.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 3.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.5 | 4.0 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.5 | 3.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.5 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 0.5 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.5 | 3.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.5 | 6.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.5 | 1.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 9.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.5 | 1.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 5.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 1.9 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 0.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.5 | 0.5 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.5 | 1.9 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.5 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 0.9 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 1.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.5 | 1.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 0.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 2.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 0.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 3.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 1.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 1.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 1.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.5 | 1.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 1.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 10.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 4.5 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 0.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 1.8 | GO:0039536 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 1.8 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.4 | 1.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 3.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 0.4 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.4 | 3.9 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 1.7 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 2.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 3.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.4 | 1.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 1.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 2.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 2.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.3 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 2.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 1.7 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.4 | 3.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 1.2 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 2.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 0.8 | GO:0030421 | defecation(GO:0030421) |
0.4 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.4 | 4.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 2.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 3.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 6.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 0.8 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 1.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 0.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 4.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 2.8 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.4 | 0.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.4 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 2.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 5.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 0.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 1.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 1.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 7.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 0.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.8 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 0.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 5.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 1.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 3.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 1.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 1.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 2.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 1.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 2.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 4.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 0.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.8 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.4 | 1.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 1.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 1.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 1.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.4 | 6.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 8.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 1.1 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
0.4 | 1.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 8.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 2.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.4 | 1.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 2.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 1.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.7 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.3 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 1.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 2.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 2.0 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 6.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 1.9 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 2.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 0.9 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 1.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 1.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.3 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 1.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 0.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 2.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 0.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 4.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 6.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 3.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 2.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.3 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.3 | 0.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 3.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 1.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.6 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 2.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.9 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 2.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 2.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 3.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 2.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 0.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.6 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 3.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.3 | 1.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 2.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.8 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 1.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 2.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 1.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.5 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 3.4 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 2.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 2.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.8 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.3 | 5.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 2.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 1.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 3.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 2.0 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.2 | 0.7 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.2 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.2 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 0.7 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.2 | 2.9 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.7 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 2.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 0.5 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 0.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.7 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 2.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 1.8 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.2 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 2.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 0.7 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 1.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 3.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.7 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 1.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 2.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 3.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 2.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.2 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.2 | 0.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.4 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.2 | 0.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 0.6 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.2 | 1.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.6 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 5.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.4 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.2 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 1.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.2 | 0.6 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.8 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 4.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.8 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 1.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 1.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.2 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 1.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.2 | 0.9 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.4 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.7 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 0.7 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 5.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 0.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.2 | 0.4 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 6.5 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.3 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.2 | GO:0051503 | purine nucleotide transport(GO:0015865) adenine nucleotide transport(GO:0051503) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.9 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 4.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 1.0 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 1.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 0.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 4.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 1.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 7.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 1.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.8 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 3.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 1.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.2 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 1.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 3.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.3 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.1 | 2.2 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 1.9 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 3.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.7 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 3.0 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 2.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.3 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.1 | 0.1 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 2.7 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 2.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.4 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 3.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 3.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 4.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.7 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 5.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 1.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 1.8 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.8 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.3 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.6 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.1 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.1 | 0.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 2.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.5 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 1.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.6 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.7 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0072537 | fibroblast activation(GO:0072537) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.2 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 1.0 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 4.0 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 2.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 1.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0010742 | macrophage derived foam cell differentiation(GO:0010742) regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 1.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.9 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 1.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.3 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 2.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0033079 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 2.2 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 1.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.1 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.1 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 1.2 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.9 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 4.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.5 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 1.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.0 | 0.1 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
0.0 | 2.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 1.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.3 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.6 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.0 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 1.3 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.0 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.2 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0009309 | polyamine biosynthetic process(GO:0006596) amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.0 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 19.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.1 | 6.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 4.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.6 | 7.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.6 | 7.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.4 | 11.3 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 6.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 5.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 3.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.1 | 3.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 5.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.0 | 5.8 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 5.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.9 | 13.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.8 | 2.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 6.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 6.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.8 | 3.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 3.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 3.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 2.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 8.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 2.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 3.6 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 2.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 2.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 9.0 | GO:0036379 | myofilament(GO:0036379) |
0.6 | 1.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 7.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 2.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 3.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 37.5 | GO:0030018 | Z disc(GO:0030018) |
0.5 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 2.3 | GO:0031430 | M band(GO:0031430) |
0.5 | 0.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.4 | 3.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 1.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 3.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 1.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 4.7 | GO:0031674 | I band(GO:0031674) |
0.4 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 3.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 4.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 6.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 5.6 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 5.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 2.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 16.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 2.9 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 2.2 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 2.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 3.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 7.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 2.0 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 3.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 3.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 1.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 5.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 3.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.3 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 4.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 3.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 3.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 12.7 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 2.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 4.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.7 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 5.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 2.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 13.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 4.2 | GO:0030017 | sarcomere(GO:0030017) |
0.2 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 16.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 5.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 4.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 0.8 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 1.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 4.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 10.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 8.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 8.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.4 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 1.5 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 13.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 1.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 1.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 3.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 2.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 4.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.1 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.0 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 2.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.1 | GO:0044455 | integral component of mitochondrial membrane(GO:0032592) mitochondrial membrane part(GO:0044455) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 9.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 10.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 4.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 9.2 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 14.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 26.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 14.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 6.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 8.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 3.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 3.4 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 2.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.9 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.8 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.7 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 2.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 15.8 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 5.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 22.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.2 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 4.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 6.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.0 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 11.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 1.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 8.1 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 61.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 1.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 25.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.9 | GO:0044445 | cytosolic part(GO:0044445) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 1.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 1.6 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.7 | 8.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 8.1 | GO:0043515 | kinetochore binding(GO:0043515) |
2.0 | 8.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.9 | 7.5 | GO:0031014 | troponin T binding(GO:0031014) |
1.8 | 7.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.6 | 4.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.6 | 6.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.4 | 5.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.4 | 5.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.4 | 8.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.4 | 4.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.4 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.3 | 4.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 9.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 2.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.3 | 8.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.2 | 7.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 5.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.0 | 20.9 | GO:0030506 | ankyrin binding(GO:0030506) |
1.0 | 3.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 4.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.0 | 5.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 3.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 1.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.9 | 5.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.9 | 11.6 | GO:0016208 | AMP binding(GO:0016208) |
0.9 | 2.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 2.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.9 | 6.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 3.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.9 | 3.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 4.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 6.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.8 | 2.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 3.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 2.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 1.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.7 | 3.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.2 | GO:0004096 | catalase activity(GO:0004096) |
0.7 | 2.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 2.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 2.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 4.1 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.7 | 5.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 2.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 6.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 3.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 2.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 8.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.7 | 6.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 2.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 3.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 3.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 3.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 1.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 1.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 2.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 1.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 1.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 4.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 2.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 4.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 3.5 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 6.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 3.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 2.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 2.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 6.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 1.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 2.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 14.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 2.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 3.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 2.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 6.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 17.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 5.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 1.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 2.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 1.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 3.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 0.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 4.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 2.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 3.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 3.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 2.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 2.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 8.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 8.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 1.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 1.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 5.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 4.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 2.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 2.1 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 2.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 4.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 2.8 | GO:0043719 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 6.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 8.2 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 1.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 8.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 6.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 5.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 3.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 2.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 5.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 2.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 1.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 2.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.3 | 3.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 9.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 1.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 6.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 10.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 6.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 3.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 4.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 1.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 1.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 2.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 1.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 5.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 1.1 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 1.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 4.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 5.5 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 5.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 1.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 4.4 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 2.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 8.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 1.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.7 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 4.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 3.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 15.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 1.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 1.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 3.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 3.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 5.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 2.6 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 1.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 8.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 3.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 4.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 2.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 3.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 4.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 5.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 0.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 4.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 4.9 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 2.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 2.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 3.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 4.0 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.5 | GO:0008443 | 6-phosphofructo-2-kinase activity(GO:0003873) phosphofructokinase activity(GO:0008443) |
0.2 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 1.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.5 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 6.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 3.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 5.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 2.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 4.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.4 | GO:0004937 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 3.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 5.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 3.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 4.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 18.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 3.4 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 1.1 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 2.8 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 1.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 2.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 4.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 1.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 4.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 7.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 4.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 2.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.4 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 2.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.2 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.1 | GO:0051379 | epinephrine binding(GO:0051379) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 2.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 2.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 3.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 7.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 5.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 1.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 7.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 2.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 3.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.5 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 1.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 1.6 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 3.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 2.4 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 3.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.0 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.5 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.0 | 0.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 5.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 22.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 16.7 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 6.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 15.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 5.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 7.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 11.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 5.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 2.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 15.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 13.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 14.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 17.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 8.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 18.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 8.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 2.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 10.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 4.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 4.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 4.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 6.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 11.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 4.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 7.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 4.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 12.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 6.4 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 10.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 4.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 5.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.7 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 3.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 3.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.6 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 4.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 4.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 7.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 18.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 13.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 1.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 21.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 13.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 11.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 10.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 5.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 2.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 1.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 5.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 5.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 15.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 4.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 1.5 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.5 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.5 | 5.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 6.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 0.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.5 | 1.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 5.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 15.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 9.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 4.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 5.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 1.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 4.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 2.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 8.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 37.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 8.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 4.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 13.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 10.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 2.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 7.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 1.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 37.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 3.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 3.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 5.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 10.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 6.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 3.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 5.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 3.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 6.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 2.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 1.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 19.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 8.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 7.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 4.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 5.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 2.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 2.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 11.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 6.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 5.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 6.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 4.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 6.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.2 | 2.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 1.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.2 | 1.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 4.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 6.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 5.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 3.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 7.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 6.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 3.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 3.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 5.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 6.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 7.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 3.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 2.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 3.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 5.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 3.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 6.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 4.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 1.8 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |